Comparison of the pharmacodynamics and pharmacokinetics of insulin aspart and human soluble insulin in geriatric subjects with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 06 May 2009 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 06 May 2009 Actual end date (Jul 2002) added as reported by ClinicalTrials.gov.